Selexis SA, a JSR Life Sciences Company, is the global leader in cell line development with best-in-class modular technology and highly specialized solutions that enable the life sciences industry to rapidly discover, develop and commercialize innovative biologic medicines and vaccines. Our global partners are utilizing Selexis technologies to advance more than 130 drug products in clinical development and the manufacture of eight commercial products.
As part of a comprehensive drug development process, the Company’s technologies – offered under flexible, customized contractual agreements – shorten development timelines and reduce manufacturing risks. More information is available at www.selexis.com.
Location: Switzerland, Geneva, Arare
Member count: 51-200
Phone: +41 22 308 93 60
Founded date: 2001
Investors 1
Date | Name | Website |
- | Fongit See... | fongitseed... |
Mentions in press and media 17
Date | Title | Description | Category | Author | Source |
20.10.2020 | New manage... | Aktiia SA is a Swiss-US star... | Expansion | - | startuptic... |
20.10.2020 | New manage... | Aktiia SA is a Swiss-US start-... | - | - | startuptic... |
17.10.2019 | After 13%... | → AstraZeneca-partnered Fren... | - | Kathy Wong | endpts.com... |
16.04.2018 | Selexis in... | In May 2017, Selexis opened ... | Expansion ... | - | startuptic... |
29.11.2017 | Venture Ki... | Established in 2007, Venture... | Background... | - | startuptic... |
27.06.2017 | Mitoconi... | → Mitoconix has a neurodeg... | - | Shehla Sha... | endpts.com... |
21.02.2017 | Selexis In... | Selexis SA announced today i... | Success | - | startuptic... |
09.01.2015 | First Sele... | “This market approval repres... | - | - | startuptic... |
25.06.2014 | Developing... | Preliminary data from the Co... | - | - | startuptic... |
06.12.2013 | JHL Biotec... | The alliance leverages the s... | - | - | startuptic... |
Show more